-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
eFFECTOR Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q1 2024.
- eFFECTOR Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$438K, a 8.37% increase year-over-year.
- eFFECTOR Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$1.93M, a 440% decline year-over-year.
- eFFECTOR Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.97M, a 120% decline from 2022.
- eFFECTOR Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $9.74M, a 79.6% decline from 2021.
- eFFECTOR Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $47.7M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)